Opportunity Information: Apply for CDC RFA PS13 1311
Apply for CDC RFA PS13 1311
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Using Evidence from Science and Community Practice to Develop Web and other Technology Based Tools for HIV Treatment Service Provider Organizations to Improve Linkage, Retention, and Re Engagement of HIV Positive Persons in Care" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.941 HIV Demonstration, Research, Public and Professional Education Projects.
- This funding opportunity was created on Apr 19, 2013 and posted on Mar 25, 2013.
- Applicants must submit their applications by May 10, 2013 Letter of Intent Deadline (LOI) Date April 15, 2013, 1159 p.m. U.S. Eastern Standard Time. The LOI is a required component of the application and is intended to provide CDC with an estimated number of applicants to anticipate for the competitive process. Application Deadline Date May 10, 2013, 1159 p.m. U.S. Eastern Standard Time, on www.grants.gov. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,700,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- American Indian/Alaska Native tribal governments (federally recognized or state recognized) American Indian/Alaska native tribally designated organizations Alaska Native health corporations Colleges Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Political subdivisions of States (in consultation with States) Research institutions (that will perform activities deemed as non research) Small, minority, and women owned businesses State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). Tribal epidemiology centers Universities Urban Indian health organizations PLEASE SEE THE FULL ANNOUNCEMENT FOR SPECIAL ELIGIBILITY REQUIREMENTS.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (CDC RFA PS13-1311) is a discretionary cooperative agreement focused on improving how quickly and consistently people living with HIV get connected to medical care, stay in care over time, and return to care after dropping out. The core idea is to take what already works in the real world, both from formal scientific evidence and from proven community practice, and turn those successful approaches into practical web-based and other technology-based tools that HIV treatment service provider organizations can actually use. Rather than funding basic research, the emphasis is on identifying effective "model programs," translating them into usable digital resources, testing them with agencies that are currently struggling with linkage and retention, and then refining the tools so they can be shared more widely, including potential dissemination by CDC to clinical and community providers.
The project described in the announcement follows a clear development pipeline. First, the awardee is expected to identify model programs that have evidence-informed strategies or well-documented community best practices for improving linkage to care and retention in care. Next, those strategies are translated into technology-based tools and implementation resources that other organizations can adopt without having to reinvent the wheel. Then, those tools are pilot tested in real service settings, specifically with agencies facing measurable challenges in getting clients linked to care promptly, keeping them engaged, and re-engaging those who have fallen out of care. Finally, the tools are refined based on what the pilot shows, with the end goal of producing polished, scalable products that CDC could disseminate nationally.
The tools to be developed are meant to support three connected service goals. The first is rapid linkage: helping people who receive a positive HIV test start HIV medical care as soon as possible after diagnosis. The second is retention and re-engagement: supporting ongoing participation in HIV care, and actively bringing back people who were previously diagnosed but have stopped attending care. The third is service coordination: strengthening the network of collaborations that make linkage and retention work in practice, including coordination among HIV testing providers, community-based organizations, HIV care clinics, case managers, and health departments, with attention to antiretroviral therapy (ART) adherence as part of sustained care engagement. The announcement notes that a logic model (referenced as Figure 1 in the full FOA) ties together the problem statement, strategy, and a set of immediate, intermediate, and long-term outcomes, signaling that applicants are expected to think in terms of measurable progression from tool development to service improvements to longer-term health outcomes.
This FOA is also framed within CDC's broader cross-cutting priorities under NCHHSTP. It explicitly connects the work to health equity, meaning tools and implementation approaches should be attentive to disparities and the practical barriers different communities face in accessing and staying in care. It also aligns with Program Collaboration and Service Integration (PCSI), encouraging more coordinated and integrated prevention and treatment systems rather than siloed programs. Finally, it is positioned within broader efforts to advance public health approaches to improve sexual health, reflecting that HIV care engagement is part of overall sexual health and wellness strategies in communities.
Administratively, this was a single-award cooperative agreement with an estimated total funding amount of $2.7 million. It fell under CFDA 93.941 (HIV Demonstration, Research, Public and Professional Education Projects) and did not require cost sharing or matching. The opportunity was posted March 25, 2013, with a required Letter of Intent due April 15, 2013 (11:59 p.m. Eastern), and the full application due May 10, 2013 (11:59 p.m. Eastern) via Grants.gov; it was archived June 9, 2013. Eligibility was broad and included many types of entities involved in HIV services and public health infrastructure, such as state, local, territorial, and tribal governments and their agents; tribal organizations and epidemiology centers; universities and colleges; hospitals; research institutions performing non-research activities; community-based and faith-based organizations; nonprofits with or without 501(c)(3) status; and certain for-profit organizations, including small, minority-, and women-owned businesses (with the caveat that special eligibility requirements were referenced in the full announcement). For access issues related to the full FOA, the notice listed the CDC Procurement and Grants Office Technical Information Management Section (TIMS) as the point of contact.
Funding Opportunity FAQs (CDC RFA PS13-1311)
What is CDC RFA PS13-1311?
CDC RFA PS13-1311 is a discretionary cooperative agreement focused on improving how quickly and consistently people living with HIV (PLWH) are linked to HIV medical care after diagnosis, retained in care over time, and re-engaged in care if they fall out of care.
What is the main purpose of this cooperative agreement?
The purpose is to take strategies that already work in real-world settings (from evidence-informed approaches and well-documented community best practices) and translate them into practical web-based and other technology-based tools that HIV treatment service provider organizations can use.
Is this opportunity funding basic research?
No. The emphasis is not on basic research. It is focused on identifying effective model programs, translating them into usable technology-based tools and implementation resources, pilot testing those tools with agencies that have measurable linkage/retention challenges, and refining the products so they can be shared more widely.
What kinds of tools or products are expected from this project?
The announcement describes development of web-based and other technology-based tools and related implementation resources that organizations can adopt to improve rapid linkage to care, retention in care, and re-engagement in care, without having to reinvent successful approaches.
What are the core service goals the tools are meant to support?
The tools are intended to support three connected service goals: (1) rapid linkage to HIV medical care after a positive test, (2) retention in care and re-engagement of people who have dropped out of care, and (3) service coordination across the organizations involved in linkage and retention.
What does "rapid linkage" mean in this FOA?
Rapid linkage refers to helping a person who receives a positive HIV test start HIV medical care as soon as possible after diagnosis.
What does "retention and re-engagement" mean in this FOA?
Retention and re-engagement refers to supporting ongoing participation in HIV medical care over time and actively bringing back individuals who were previously diagnosed but have stopped attending care.
What does "service coordination" include according to the announcement?
Service coordination includes strengthening collaboration among HIV testing providers, community-based organizations, HIV care clinics, case managers, and health departments. The announcement also notes attention to antiretroviral therapy (ART) adherence as part of sustained care engagement.
What is meant by identifying "model programs"?
Model programs are programs with evidence-informed strategies or well-documented community best practices that have been shown to improve linkage to care and retention in care. The awardee is expected to identify these programs first, before translating them into tools.
What is the development pipeline described in the FOA?
The pipeline described is: (1) identify model programs, (2) translate successful strategies into technology-based tools and implementation resources, (3) pilot test tools in real service settings with agencies facing measurable linkage/retention challenges, and (4) refine the tools based on pilot results to produce scalable products that could be disseminated more widely.
Who are the pilot test sites expected to be?
Pilot testing is expected to occur in real service settings, specifically with agencies that are currently struggling with linkage to care, retention in care, and/or re-engagement of people who have fallen out of care, and where those challenges are measurable.
What is the end goal for dissemination of the tools?
The end goal is to produce polished, scalable products that can be shared widely, including potential national dissemination by CDC to clinical and community providers.
Does the FOA mention how outcomes should be framed or measured?
Yes. The announcement references a logic model (Figure 1 in the full FOA) linking the problem statement and strategies to immediate, intermediate, and long-term outcomes. This signals that applicants are expected to think in measurable stages from tool development to service improvements to longer-term health outcomes.
How does this opportunity connect to CDC/NCHHSTP priorities?
The FOA is framed within broader cross-cutting priorities under NCHHSTP, including health equity, Program Collaboration and Service Integration (PCSI), and broader public health efforts to improve sexual health.
What does the FOA mean by health equity in this context?
Health equity is explicitly referenced, indicating that tools and implementation approaches should be attentive to disparities and the practical barriers different communities face in accessing and staying in HIV medical care.
What is PCSI and how is it reflected in this FOA?
PCSI stands for Program Collaboration and Service Integration. The FOA aligns with PCSI by encouraging coordinated and integrated prevention and treatment systems rather than siloed programs.
What is the total estimated funding amount and award structure?
This was described as a single-award cooperative agreement with an estimated total funding amount of $2.7 million.
What CFDA number is associated with this opportunity?
The opportunity was listed under CFDA 93.941 (HIV Demonstration, Research, Public and Professional Education Projects).
Was cost sharing or matching required?
No. The announcement states that cost sharing or matching was not required.
When was the opportunity posted and when was it due?
The opportunity was posted on March 25, 2013. A Letter of Intent was due April 15, 2013 (11:59 p.m. Eastern), and the full application was due May 10, 2013 (11:59 p.m. Eastern).
How were applications submitted?
Applications were to be submitted via Grants.gov.
Is this funding opportunity still open?
No. The listing indicates the opportunity was archived on June 9, 2013.
Who was eligible to apply?
Eligibility was described as broad and included state, local, territorial, and tribal governments and their agents; tribal organizations and epidemiology centers; universities and colleges; hospitals; research institutions performing non-research activities; community-based and faith-based organizations; nonprofits with or without 501(c)(3) status; and certain for-profit organizations, including small, minority-, and women-owned businesses (with special eligibility requirements referenced in the full announcement).
Are for-profit organizations allowed to apply?
Yes. The eligibility description includes certain for-profit organizations, including small, minority-, and women-owned businesses, with the note that special eligibility requirements were referenced in the full announcement.
Who was listed as the point of contact for access issues with the full FOA?
For access issues related to the full FOA, the notice listed the CDC Procurement and Grants Office Technical Information Management Section (TIMS) as the point of contact.
What type of activities are emphasized for the awardee?
Activities emphasized include identifying effective real-world programs, translating those approaches into digital tools and implementation resources, pilot testing them with agencies that have measurable problems with linkage/retention/re-engagement, and refining tools to support broader dissemination.
What types of organizations are intended to use the tools created?
The tools are intended for HIV treatment service provider organizations and are described as suitable for clinical and community providers, including organizations involved in testing, care delivery, case management, community support, and public health coordination.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Visitor Facility Enhancement
Previous opportunity: Notice of Intent to Award Independence Visitor Center Operation, Use and Maintenance
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS13 1311
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS13 1311) also looked into and applied for these:
| Funding Opportunity |
|---|
| Drug Target Development and Validation for Antimicrobial Resistant Pathogens (R21/R33) Apply for RFA AI 13 019 Funding Number: RFA AI 13 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01) Apply for RFA AA 13 003 Funding Number: RFA AA 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R21) Apply for RFA AA 13 004 Funding Number: RFA AA 13 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Functional Characterization of Oral Cancer Initiating Cells (R01) Apply for RFA DE 14 001 Funding Number: RFA DE 14 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Functional Characterization of Oral Cancer Initiating Cells (R21) Apply for RFA DE 14 002 Funding Number: RFA DE 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| KNOWLEDGE FOR HEALTH II Apply for SOL OAA 13 000048 Funding Number: SOL OAA 13 000048 Agency: Agency for International Development Category: Health Funding Amount: $40,000,000 |
| Using Traditional Foods and Sustainable Ecological Approaches for Health Promotion and Diabetes Prevention in American Indian/Alaska Native (AI/AN) Communities CC RFA DP08 819 Apply for CDC RFA DP13 1317 Funding Number: CDC RFA DP13 1317 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Delta Health Care Services Program Apply for RBS01 2012 DHCS Funding Number: RBS01 2012 DHCS Agency: Business and Cooperative Programs Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services, and Recovery Research (R01) Apply for PA 13 160 Funding Number: PA 13 160 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services, and Recovery Research (R21) Apply for PA 13 161 Funding Number: PA 13 161 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Alcohol Use Disorders Treatment, Services, and Recovery Research (R03) Apply for PA 13 162 Funding Number: PA 13 162 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immunodeficiency (SCID) Apply for CDC RFA EH13 1303 Funding Number: CDC RFA EH13 1303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Strategic Prevention Framework Partnerships for Success (SPF PFS) Apply for SP 13 004 Funding Number: SP 13 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $2,260,000 |
| Secondary Analyses of Existing Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Apply for PA 13 168 Funding Number: PA 13 168 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genomic Medicine Pilot Demonstration Projects (U01) Apply for RFA HG 13 004 Funding Number: RFA HG 13 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving HIV Prevention and Treatment Outcomes Among HIV Infected Persons by Integrating Community Pharmacists and Clinical Sites into a Model of Patient centered HIV Care Apply for CDC RFA PS13 1315 Funding Number: CDC RFA PS13 1315 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,300,000 |
| Medical Professionals Recruitment and Continuing Education Programs Apply for HHS 2013 IHS HPR 0001 Funding Number: HHS 2013 IHS HPR 0001 Agency: Indian Health Service Category: Health Funding Amount: $25,000 |
| NIDCR Small Research Grants for Secondary Analysis of FaceBase Data (R03) Apply for PAR 13 178 Funding Number: PAR 13 178 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Undiagnosed Diseases Gene Function Research (R21) Apply for RFA RM 13 003 Funding Number: RFA RM 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Implementation Science for Strengthening Use of Evidence in Family Planning/Reproductive Health Programming (ISSUE FP/RH) Apply for SOL OAA 13 000005 Funding Number: SOL OAA 13 000005 Agency: Agency for International Development Category: Health Funding Amount: $150,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS13 1311", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.